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A B S T R A C T
Background
The efficient allocation of financial resources for malaria control using appropriate
combinations of interventions requires accurate information on the geographic distribution
of malaria risk. An evidence-based description of the global range of Plasmodium falciparum
malaria and its endemicity has not been assembled in almost 40 y. This paper aims to define
the global geographic distribution of P. falciparum malaria in 2007 and to provide a preliminary
description of its transmission intensity within this range.
Methods and Findings
The global spatial distribution of P. falciparum malaria was generated using nationally
reported case-incidence data, medical intelligence, and biological rules of transmission
exclusion, using temperature and aridity limits informed by the bionomics of dominant
Anopheles vector species. A total of 4,278 spatially unique cross-sectional survey estimates of P.
falciparum parasite rates were assembled. Extractions from a population surface showed that
2.37 billion people lived in areas at any risk of P. falciparum transmission in 2007. Globally,
almost 1 billion people lived under unstable, or extremely low, malaria risk. Almost all P.
falciparum parasite rates above 50% were reported in Africa in a latitude band consistent with
the distribution of Anopheles gambiae s.s. Conditions of low parasite prevalence were also
common in Africa, however. Outside of Africa, P. falciparum malaria prevalence is largely
hypoendemic (less than 10%), with the median below 5% in the areas surveyed.
Conclusions
This new map is a plausible representation of the current extent of P. falciparum risk and the
most contemporary summary of the population at risk of P. falciparum malaria within these
limits. For 1 billion people at risk of unstable malaria transmission, elimination is
epidemiologically feasible, and large areas of Africa are more amenable to control than
appreciated previously. The release of this information in the public domain will help focus
future resources for P. falciparum malaria control and elimination.
The Editors’ Summary of this article follows the references.
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Introduction
The magnitude of the public health burden posed by
malaria worldwide [1] and its connection to poverty [2] has
galvanized the international donor community to put malaria
control high on the development agenda and helped leverage
unprecedented additional ﬁnancing for malaria endemic
countries [3]. Progress toward agreed targets of intervention
coverage has been slow [4–6], but recent evidence indicates a
precipitous increase in access to effective drugs and
prevention strategies in several countries [7–10]. In part, this
renaissance in malaria control has served as a catalyst to
revisit the possibility of malaria elimination in many regions
and countries [11–14]. A changing malaria landscape requires
an accurate spatial and dynamic description of malaria risk
that maps the spatial extent and need for control and
elimination over the coming decades. Such a map is
conspicuous by its absence [15].
Here, we present the ﬁrst detailed description of the global
distribution of P. falciparum risk in 40 y [16,17] by using
geopositioned assemblies of national surveillance of malaria
risk, medical intelligence, biological models of transmission
suitability, and surveys of parasite prevalence. The paper
focuses on detailing the data sources and their adaptation for
the malaria cartography necessary to guide current disease
control, with an emphasis on how we deﬁne the spatial limits
of stable and unstable P. falciparum risk worldwide.
Methods
Using Medical Intelligence to Define the Limits of P.
falciparum Risk
Many countries have information assembled from medical
intelligence on the distribution of malaria risk within their
national borders. This information is documented primarily
in reports from national health information systems that
deﬁne the annual numbers of conﬁrmed parasite-speciﬁc
local malaria infections by geographic unit, referred to
classically as the annual parasite incidence (API) [18–21].
The API is generated from various combinations of active
(fever surveys in communities where every person presenting
with a fever is tested for parasite infection) and passive
(reports from febrile patients attending the local health
services) case detection, and usually expresses the combined
results as the number infected per 1,000 people per annum
(pa) [18–21]. The precision of these estimates of malaria
incidence are highly variable, and with the exception of some
countries where case identiﬁcation is a primary control tool
[22], these data cannot be used conﬁdently to derive the
public health burden posed by malaria [1,23–26]. They can,
however, be a useful indicator of where local parasite species-
speciﬁc malaria risk is likely or absent, and are particularly
plausible when triangulated with other sources of medical
intelligence, reported in international travel health guide-
lines or by national malaria control programmes.
Malaria coordinating ofﬁcers in the regional ofﬁces of the
World Health Organization (WHO), responsible for the
collation of national API data from member countries were
contacted to obtain data reported nationally to the highest
possible geographic administrative unit level on populations
at risk and numbers of conﬁrmed P. falciparum cases, for as
many years as were available between 2002 and 2006. Among
the countries in the American Regional Ofﬁce, P. falciparum–
speciﬁc API (PfAPI) data from national surveillance systems
in Brazil, Colombia, Peru, and Honduras were obtained
directly from personal communication with malaria special-
ists. The reported cases of conﬁrmed P. falciparum malaria per
1,000 resident population were computed for each year by
administrative level and averaged over the number of
reporting years. Summary data were categorized as no
autochthonous P. falciparum cases reported, ,0.1 autochtho-
nous P. falciparum cases per 1,000 people pa, and 0.1
autochthonous P. falciparum cases per 1,000 people pa. The
threshold around 0.1 cases per thousand pa was used to
provide some indication of unstable conditions versus more
stable transmission. This threshold is consistent with previous
uses of PfAPI during the Global Malaria Eradication
Programme [27] and balanced against the conﬁdence in the
precision of reported PfAPI values (Protocol S1). Each PfAPI
summary estimate was mapped by matching it to its
corresponding ﬁrst-, second-, or third-level administrative
unit in a geographic information system (GIS; ArcView GIS
3.2, ESRI, 1999).
Mapped PfAPI data were then compared to other sources
of medical intelligence, notably national malaria control
presentations at regional malaria meetings obtained from
regional WHO malaria coordinators and from Web sites,
published sources that described national malaria epidemi-
ology, and international travel and health guidelines [28,29].
These combined approaches were particularly useful to
identify mapped descriptions of risk deﬁned at higher spatial
resolution than those described by the PfAPI reported across
large ﬁrst-level administrative units. Details of all sources
used are provided in Protocol S1.
Defining the Biological Limits of P. falciparum
Transmission
Within the limits of risk described through PfAPI, environ-
mental conditions suitable for transmission vary enormously.
These variations can be captured at much higher spatial
resolution than it is possible to deﬁne by stratifying risk at
administrative unit levels. Climate-based determinants of
parasite and vector development and survival were developed
that impose biological constraints on the geographical limits
of P. falciparum transmission.
First, we used a combination of the temperature-depend-
ant relationship between P. falciparum sporogony and the
longevity of the main dominant vectors to estimate the
proportion of vectors surviving parasite development (Pro-
tocol S2). Using mean monthly temperature records from a
30-arcsec (;1 km) spatial resolution climate surface [30], the
duration of P. falciparum sporogony was estimated for each
synoptic calendar month, and those pixels where the duration
of sporogony was 31 d or less were identiﬁed. The exception
was small areas that potentially support the longer-lived
Anopheles sergentii and A. superpictus, where 62 d were
considered more appropriate biologically (Protocol S2). This
resulted in 12 images with a binary outcome: P. falciparum
sporogony could or could not be completed in the month.
These images were then combined to identify the number of
suitable months for P. falciparum transmission in a synoptic
year. All pixels where the duration of sporogony exceeded 1
mo, or 2 mo for areas within the range of A. sergentii and A.
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superpictus, were masked since it was highly unlikely that
transmission would occur.
Second, there are areas within several malaria endemic
countries where, despite temperature being suitable for
sporogony, arid conditions restrict Anopheles development
and survival [31]. Limited surface water reduces the avail-
ability of water bodies for oviposition. Moreover, low ambient
humidity in arid environments further affects egg and adult
survival through the process of desiccation [32]. The ability of
adult vectors to survive long enough to contribute to parasite
transmission and of preadult stages to ensure minimum
population abundance is, therefore, dependent on the levels
of aridity and species-speciﬁc resilience to arid conditions.
To capture the inﬂuence of aridity on transmission we used
the enhanced vegetation index (EVI) derived from the
bidirectional reﬂectance-corrected MODerate-resolution
Imaging Spectroradiometer (MODIS) sensor imagery, avail-
able at approximately 1-km spatial resolution [33,34] (Proto-
col S2). Temporal Fourier–processed, monthly EVI images
were used to develop 12 monthly surfaces that reclassiﬁed
EVI  0.1, assuming this corresponded to a good proxy for
arid conditions [35,36]. Pixels were classiﬁed as suitable for
transmission if their EVI values were higher than 0.1 for at
least two consecutive months in an average year. This
deﬁnition was based on the biological requirement, at
optimum temperatures, of at least 12 d to complete vector
development from egg to adult [37] and on the assumption
that a second month is required for a sufﬁcient vector
population to establish and transmit malaria [38]. These
reclassiﬁed aridity images were then overlaid in a GIS to
produce 12 paired images. The 12 pairs were then combined
to deﬁne pixels where conditions were suitable for trans-
mission. The aridity mask was treated differently from the
temperature-limiting mask to allow for the possibility, in arid
environments, of highly over-dispersed transmission due to
man-made water collection points and nomadic human
populations transporting vectors and parasites [39–41]. A
more conservative approach was taken, therefore, which
down-regulated PfAPI risk by one class. In other words,
extremely arid areas deﬁned originally as at stable risk were
stepped down to unstable risk and those classiﬁed initially as
unstable to malaria free.
Estimating Populations at P. falciparum Transmission Risk
in 2007
The Global Rural Urban Mapping Project alpha version
provides gridded population counts and population density
estimates for the years 1990, 1995, and 2000, both adjusted
and unadjusted to the United Nations’ national population
estimates [42]. We used the adjusted population counts for
the year 2000 and projected them to 2007 by applying
national, medium variant, intercensal growth rates by
country [43], using methods previously described [44]. This
resulted in a contemporary population density surface of
approximately 1-km spatial resolution, which was combined
with the climate-adjusted PfAPI risk surface to extract
population at risk estimates using ArcView GIS 3.2 (ESRI,
1999).
Describing Global Patterns of Parasite Prevalence
We have described previously the rigorous process of
identifying, assembling, and geolocating community-based
survey estimates of parasite prevalence undertaken since
1985 [45]. These data were used here to deﬁne the ranges of P.
falciparum parasite prevalence rates (PfPR) in areas of stable
and unstable malaria risk by WHO region. We acknowledge
that these geopolitical boundaries do not necessarily conform
to ecological or biological spatial representations of malaria
[46,47]. They do, however, represent coherent regions of
collective planning and cooperation for malaria control. In
an attempt to minimize epidemiologically unrealistic divides
for summary purposes, we have combined the Southeast
Asian (SEARO) and Western Paciﬁc (WPRO), as well as the
Eastern Mediterranean (EMRO) and European (EURO)
regions. The American WHO region (AMRO) and the African
WHO region (AFRO) were considered separately. PfPR
estimates were reported in various age groupings. To stand-
ardize to a single, representative age range of 2–10 y, we
applied an algorithm based on catalytic conversion models
ﬁrst adapted for malaria by Pull and Grab [48] and described
in detail elsewhere [49]. The geolocated and age-standardized
prevalence data (PfPR210) [45] were overlaid on the PfAPI
risk surface to extract a corresponding PfAPI value.
Results
PfAPI Data and Medical Intelligence to Define Spatial
Limits of Transmission
The PfAPI data identiﬁed 87 countries at risk of P.
falciparum transmission between 2002 and 2006, which we
now consider as P. falciparum endemic countries (PfMEC) in
2007 (Protocol S1). PfAPI data were mapped to ﬁrst, second,
or third administrative level units across 41 PfMECs covering
a total of 8,789 unique polygons. These data incorporate
complete years between 2002 and 2006, including summaries
of three consecutive years for 16 countries, two consecutive
years for eight countries, and the most recent complete year
for 17 countries (Protocol S1). No information was available
for 46 countries; mostly those in Africa. The spatial
representation of no risk, unstable (PfAPI , 0.1 per 1,000
people pa), and stable risk (PfAPI  0.1 per 1,000 people pa)
of P. falciparum transmission globally is shown in Figure 1, top
panel.
Temperature and Aridity Masks to Constrain Limits of
Transmission
Within the PfAPI limits of stable transmission (PfAPI  0.1
per 1,000 pa) on the African continent, the areas with no
temperature-suitable months for transmission were congru-
ent with the high altitude areas in Ethiopia, Eritrea, western
Kenya, eastern Tanzania, Rwanda, Burundi, eastern Demo-
cratic Republic of the Congo, the Malagasy highlands, Mount
Cameroon, and the eastern highland ranges in Zimbabwe
(Figure 1, bottom panel). Outside of Africa, there was a close
correspondence between the areas masked by the absence of
reported autochthonous cases and areas classiﬁed as unsuit-
able for transmission based on low temperature in Andean
and Himalayan areas (Figure 1, bottom panel). The applica-
tion of the temperature mask provided a ﬁner spatial
resolution constraint to PfAPI data, particularly for the
island of New Guinea and the highlands neighbouring the city
of Sana’a, Yemen. Important reductions in the spatial areas of
risk were also evident in some administrative units in
Afghanistan, Bhutan, China, India, and Kyrgyzstan.
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The aridity mask constrained the mapped P. falciparum
transmission risk to small pockets in large administrative
boundaries from southern areas of Hilmand and Kandahar,
in Afghanistan, the municipality of Djibouti, in Djibouti, and
the south-eastern provinces of Iran. The risk areas along the
Red Sea coast of Saudi Arabia were also reduced further
using the aridity mask. Additional areas constrained within
their spatial margins to no risk using the aridity mask
included administrative units in India (n¼ 4), Pakistan (n¼ 9),
Peru (n¼ 3), Kyrgyzstan (n¼ 2), Tajikistan (n¼ 1), and the low
risk areas of Namibia bordering the Namib desert. Large
areas covered by the aridity mask were reduced from stable
(PfAPI  0.1 per 1,000 pa) to unstable risk (PfAPI , 0.1 per
1,000 pa) in the Sahel. The transmission reducing effects of
aridity were also evidenced in Djibouti, Eritrea, northwest
Kenya, northeast Ethiopia, northern Somalia, central and
coastal areas of Yemen, and southern Pakistan. Importantly,
these areas retained small pockets of higher, more-suitable
transmission conditions, corresponding to river tributaries
and irrigated land where higher transmission risk is
supported [50].
Populations at Risk
Table 1 provides a summary of the spatial extents and the
projected 2007 populations at risk (PAR) within areas of
assumed unstable (PfAPI , 0.1 per 1,000 pa) and stable P.
falciparum transmission (PfAPI  0.1 per 1,000 pa) globally and
by WHO region. Country PAR estimations are also provided
(Table S1). We estimate that there are 2.37 billion people at
risk of P. falciparum transmission worldwide, 26% located in
the AFRO region and 62% in the combined SEARO-WPRO
regions (Table 1). The deﬁnition of unstable risk outlined
here is the predominant feature of exposure to transmission
in the EMRO-EURO region (Table 1). Low-risk areas in AFRO
were also coincident with arid, low population density areas.
Globally, 42% of the population exposed to some risk of P.
falciparum was classiﬁed as inhabiting areas of unstable
transmission; the total population in these areas was 0.98
billion people.
Figure 1. P. falciparum Malaria Risk Defined by Annual Parasite Incidence (top), Temperature, and Aridity (bottom)
Areas were defined as stable (dark-red areas, where PfAPI  0.1 per thousand pa), unstable (pink areas, where PfAPI , 0.1 per thousand pa), or no risk
(light grey). The few areas for which no PfAPI data could be obtained, mainly found in India, are coloured in dark grey. The borders of the 87 countries
defined as P. falciparum endemic are shown. Highland areas where risk was excluded due to temperature appear in light grey. The aridity mask
excluded risk in a step-wise fashion, reflected mainly in the larger extents of unstable (pink) areas compared to the top panel, particularly in the Sahel
and southwest Asia (southern Iran and Pakistan).
doi:10.1371/journal.pmed.0050038.g001
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Global and Regional Summary of P. falciparum Parasite
Prevalence
The summary data on age-corrected PfPR are presented
without adjustments for biological and climatic covariates,
urbanization, congruence with dominant Anopheles vector
species, or any sampling issues inherent in an opportunistic
sample of this kind. This is the subject of ongoing work. The
summarized data, however, do provide important new
insights into the ranges of infection prevalence reported
between regions of the world within the P. falciparum spatial
limits of stable and unstable transmission. A total of 4,278
spatially unique cross-sectional survey estimates of PfPR were
assembled as part of the activities of the Malaria Atlas Project
(MAP) by 01 September 2007. These included 186 (4.4%)
surveys that were not possible to geolocate and are not
considered further in the analysis. Of the positioned survey
data, 3,700 (90.4%) were derived from individual commun-
ities (about 10 km2 or less), 131 from wide areas (more than
about 10 km2 and about 25 km2 or less), 145 from small
polygons (more than about 25 km2 and about 100 km2 or less),
and 116 from large polygons (more than about 100 km2) [45].
A total of 406 surveys were undertaken outside the deﬁned
spatial limits of P. falciparum transmission, of which 46
reported presence of P. falciparum infection in the popula-
tions surveyed and 360 reported zero prevalence after
allowing for a 10-km buffer around the limits. Thus, the
overall sensitivity adjusting for plausible positioning errors
[51] was 98.5%. There were 611 surveys falling inside the
limits that reported zero prevalence. Even using the 10-km
buffer the speciﬁcity of the limits was low (37.1%). This
reﬂects the difﬁculties in estimating zero prevalence without
large sample sizes [52], as well as the over-dispersed nature of
infection risks between communities within small spatial
scales [53].
The global diversity of the age-corrected PfPR2–10 estimates
within the limits of transmission is shown in Figures 2–5. A
total of 253 surveys reported zero prevalence among 2,121
surveys undertaken in AFRO (Figure 2). Outside of Africa,
358 surveys reported zero prevalence among 1,565 surveys
undertaken within the deﬁned limits of transmission. Over
92% and 95% of surveys reporting PfPR2–10  50% and 
75%, respectively, were located in AFRO and concentrated
mostly between 158 latitude north and south, areas inhabited
Table 1. Area and Population at Risk of P. falciparum Malaria in
2007
Region Area
(million km2)
PAR at PfAPI
0.1% pa
(billion)
PAR at PfAPI
,0.1% pa
(billion)
Total
PAR
(billion)
AFRO 18.81 0.60 0.01 0.61
AMRO 8.23 0.04 0.05 0.09
EMRO-EURO 5.06 0.09 0.10 0.19
SEARO-WPRO 8.04 0.66 0.82 1.48
Globe 40.14 1.39 0.98 2.37
Detailed country estimates are presented in Table S1.
%, per thousand.
doi:10.1371/journal.pmed.0050038.t001
Figure 2. Community Surveys of P. falciparum Prevalence Conducted between 1985 and 2007 in AFRO
Other regions are shown in Figures 3–5. Of the 4,278 surveys reported globally, 4,092 could be geopositioned of which 3,686, shown in these figures,
fell within the predicted limits of P. falciparum malaria risk. A total of 406 records, not shown in the figures, were found outside the limits, of which 46
reported presence of P. falciparum. Data shown are age-standardized (PfPR2–10) and represented as a continuum from zero to 100%. Table 2 and Figure
6 present detailed descriptive statistics for these data.
doi:10.1371/journal.pmed.0050038.g002
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by Anopheles gambiae s.s. [54] (Figure 2). Conversely lower
estimates of PfPR2–10 were described among those surveys
conducted in areas occupying the A. arabiensis–dominant
regions along the Sahel, horn, and southern areas of Africa
[54] (Figure 2). In AMRO (Figure 3) and EMRO-EURO (Figure
4), 87% and 65% of surveys reported PfPR2–10 below 10%,
respectively, referred to classically as hypoendemic. Over
65% of PfPR2–10 survey estimates in the combined SEARO-
WPRO region reported infection prevalence below 10%
(Figure 5), including 218 surveys reporting zero prevalence.
Despite notable gaps in the coverage of PfPR2–10 data in
many areas (Figures 2–5), a summary of the ranges of
prevalence survey estimates is provided in Table 2 and Figure
6. These data are presented for the whole time period (Figure
6, top panel) and stratiﬁed by time (Figure 6, middle and
bottom panels). We stress that these data are not spatially
congruent and therefore should not be viewed as represent-
ing secular changes in PfPR2–10 estimates by WHO region.
The data used for the bottom panel of Figure 6 are
potentially of greater value, however, when describing the
endemicity characteristics of malaria within the spatial limits
shown in Figure 1, as they represent the most contemporary
summary of malaria endemicity judged by PfPR2–10.
Discussion
We have triangulated as much information as we could
assemble from exhaustive searches to provide an improved
evidence-based description of the limits of P. falciparum
transmission globally. The spatial referencing of health
statistics, medical intelligence, and national expert opinion
represents, to our knowledge, the most complete, current
framework to understand the global distribution of P.
falciparum risk in 2007. The use of plausible biological
constraints upon transmission, based on long-term temper-
ature data and remotely sensed correlates of vegetation cover,
improved the spatial precision of the limits and categories of
risk. We estimate that there were 2.37 billion people at risk of
P. falciparum worldwide in 2007, and 40.1 million km2 of the
world might be able to support P. falciparum transmission.
Assembling geographic information on disease risk is an
iterative process, building on new data and identifying gaps
in our knowledge. We have presented previously the
distribution of P. falciparum using historical descriptions of
risk [1,16] and through the reconciliation of information in
multiple travel advisories [55,56]. None have been perfect
representations of contemporary malaria distributions
worldwide, but such work has initiated a dialogue on the
importance of providing an evidence base to malaria
cartography and in the sharing of this information [15].
We have not considered the spatial distribution of P. vivax
in this paper for a number of methodological reasons. First,
the accuracy of health reporting systems for P. vivax clinical
cases in areas of coincidental P. falciparum risk is notoriously
poor [57]. Second, the climatic constraints on parasite–vector
survival are less well deﬁned and thus harder to predict using
standardized regional-speciﬁc vector bionomics [58]. Third,
the combined effects of a prolonged liver stage and the
consequences upon natural and drug-resistant recrudescence
make the interpretation of prevalence data considerably
harder for P. vivax compared to P. falciparum [59]. We are
acutely aware that the spatial extent and disease burden of P.
Figure 3. Community Surveys of P. falciparum Prevalence Conducted between 1985 and 2007 in AMRO
doi:10.1371/journal.pmed.0050038.g003
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vivax merits more attention than it has received, but to
achieve an informed evidence-based map similar to that of P.
falciparum demands a more fundamental construction of the
basic biology of transmission and clinical epidemiology
before this can be attempted effectively.
We have been cautious in the use of the PfAPI data
reported at national levels, recognizing the inadequacies and
incompleteness of malaria surveillance [1,23–26]. The inten-
tion has been to identify administrative reporting areas that
had not detected cases of P. falciparum malaria between 2002
and 2006. It was also recognized that there existed a wide
range of reported PfAPI estimates, from one case per 100,000
people pa to reports of conﬁrmed cases in almost 50% of the
population every year, which presents a problem for the
classiﬁcation of risk. We therefore applied threshold criteria
that would distinguish areas of low clinical risk (i.e., those
areas reporting few cases and likely to support unstable
transmission conditions) from areas with higher reported
case incidence and probably more stable in their P. falciparum
transmission characteristics. Our use of a distinction between
unstable and stable transmission at 0.1 per thousand pa, while
conservative is not without precedent. During the era of the
Global Malaria Eradication Programme, epidemiologists
proposed a variety of criteria to describe malaria risk in
concert with preparatory, active, consolidation, and main-
tenance phases of elimination and ultimate ‘‘eradication’’
[60–63]. Parasite prevalence was the metric of choice for
deﬁning baseline endemicity in the preparatory phase and
was useful as an indicator of control progress in the attack
phase [52,64], until it became impossible to measure with
cost-efﬁcient sampling at very low levels of endemicity. At
this juncture, it was proposed that malaria risk be measured
through incidence metrics such as the PfAPI [65]. We
identiﬁed very few PfPR surveys (n ¼ 233) undertaken in
areas where reported PfAPI was below 0.1 per thousand pa, 70
(30%) of which reported zero prevalence (Figures 2–5); and
the median parasite prevalence was 1.4% (Table 2). It seems
appropriate, practical, and feasible to consider multiple
metrics during the assembly of malaria risk maps, and we
have combined two common malariometric measures of risk:
the PfAPI and PfPR. The mathematical relationship between
these measures and other traditional epidemiological meas-
ures, such as the basic reproduction rate of infection and the
entomological inoculation rate, is the subject of ongoing
research [61]. Stratiﬁcation of these risk areas by dominant
vector species to enable a more informed assessment of the
appropriate suites of intervention measures is also being
pursued actively [15].
The PfPR data have been assembled from peer-reviewed
literature, unpublished ministry of health sources, postgrad-
uate theses and provision of raw data from malaria scientists
in all malaria endemic regions [45]. They do not derive from
nationally representative, random-sample surveys. Their
coverage might, therefore, be subject to bias toward areas
thought to be more malarious. The inclusion of 971 geo-
positioned surveys reporting zero prevalence (including 523
[53.8%] from Africa), however, does not support this view.
Future investigation of the ecological and climatic cova-
riates of PfPR2–10 will need to move from the categorical
descriptions of over-dispersed endemicity data presented
here, to geostatistically robust estimates of risk that are
cognisant of the many potential biases in these data across
the entire limits of stable transmission shown in Figure 1. We
note, however, that as infection prevalence responds to
increased intervention coverage and access to effective
medicines, the use of traditional biological covariates might
prove less effective in predicting the distribution of P.
falciparum transmission intensity. Spatial models of PfPR
Figure 4. Community Surveys of P. falciparum Prevalence Conducted between 1985 and 2007 in EMRO-EURO
doi:10.1371/journal.pmed.0050038.g004
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distribution are being developed and tested as part of MAP’s
ongoing research to more accurately reﬂect the ranges of
malaria transmission intensity within the margins of stable
endemicity. Moreover, the PfAPI and PfPR data described in
the present paper will change with time, and future data
assemblies need to be maintained in a world with a rapidly
changing malaria epidemiology. The supporting geostatistical
models used to predict the spatial distribution of endemicity
must also therefore facilitate rapid updates. The annual
revision of the spatial limits of stable and unstable malaria,
based upon new medical intelligence, PfAPI summaries, and
the increasingly available contemporary PfPR information
will iteratively redeﬁne the cartography of malaria and be
hosted on the MAP website (http://www.map.ox.ac.uk) as a
public domain resource [15].
Assuming some degree of ﬁdelity in the descriptions of
unstable malaria used here, we estimate that one quarter
(;26%) of the malaria-endemic areas of the world are
Figure 5. Community Surveys of P. falciparum Prevalence Conducted between 1985 and 2007 in SEARO-WPRO
doi:10.1371/journal.pmed.0050038.g005
Table 2. Summaries of the P. falciparum Parasite Rate Data Reported between 1985 and 2007 and Mapped within the Spatial Limits of
P. falciparum Malaria
Region AFRO AMRO EMRO-EURO SEARO-WPRO Globe Stable Unstable
85–99 1,014 102 107 308 1,531 1,377 145
00–07 1,107 26 332 690 2,155 2,064 88
85–07 2,121 128 439 998 3,686 3,441 233
Absent 253 35 105 218 611 — —
Hypoendemic 452 76 180 434 1,142 — —
Mesoendemic 800 16 137 316 1,269 — —
Hyperendemic 400 1 11 25 437 — —
Holoendemic 216 0 6 5 227 — —
Minimum (%) 0 0 0 0 0 0 0
Q1 (%) 4.72 0 0.45 0.50 1.63 2.04 0
Median (%) 26.89 1.76 4.78 4.17 11.78 13.61 1.44
Mean (%) 32.38 4.42 11.70 11.01 23.16 24.43 5.27
Q3 (%) 54.49 4.29 15.80 16.35 39.64 41.82 5.00
Maximum (%) 99.77 50.48 99.77 93.91 99.77 99.77 63.52
The first three rows present numbers of records retrieved by time period (1985–1999 and 2000–2007) and the next five rows by endemic class [66], including absence (i.e., PfPR2–10¼ 0).
The last rows (%) present descriptive statistics of the actual PfPR2–10 values, and the last two columns show these statistics by level of risk (stable: PfAPI  0.1 per thousand pa and
unstable: PfAPI , 0.1 per thousand pa). There were 12 records falling in areas where no PfAPI data could be obtained. See Figures 2–5.
doi:10.1371/journal.pmed.0050038.t002
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exposed to some degree of unstable P. falciparum transmission
and home to approximately one (0.98) billion people. Even
within the regions with more stable transmission, the
available empirical evidence from contemporary PfPR2–10
survey data is that outside of AFRO, the intensity of
transmission is best described as hypoendemic [66] (Figure
6). This observation has important implications for how we
view malaria control and broader development goals at a
global scale over the next decade. The provisional categorical
descriptions of global P. falciparum malaria risk are shown in
Figure 1 and suggest that, at a global scale, an aggressive
approach to P. falciparum elimination might be reconsidered
as a more ambitious and achievable objective in many areas.
Regional initiatives aimed at elimination have begun [11–
14]. In the Americas, elimination is considered in the most
recent 5-y regional strategic plan [12]. In the European
region, the two PfMECs (Tajikistan and Kyrgyzstan) are
targeted for P. falciparum elimination within the next 5 y
[11,13]. Detailed plans have been developed in the Eastern
Mediterranean region to consider targeted P. falciparum
elimination strategies in Iran and Saudi Arabia, while
strengthening maintenance phases of elimination in cur-
rently P. falciparum–free countries [14]. With the exception of
EURO, detailed maps of the spatial extents of risk in these
various regions are not available. Where elimination is
considered a viable strategy, resource requirements, targets,
and maps become a regional and sub-regional public good
and are no longer solely national concerns. Saudi Arabia is
providing substantial ﬁnancial support for the elimination of
malaria in its neighbour, Yemen [67]. If this plan is successful,
the reportedly high rates of population inﬂow from Somalia
[68] will pose a continued concern due to the potential
reintroduction of the parasite. This situation further high-
lights the need for a reproducible and evidence-based global
map of malaria risk that is maintained as a dynamic platform
to estimate and predict cross-border risk.
Maintaining the detail necessary to map the spatial extent
of malaria risk is paramount to the future of malaria control
outside of Africa over the next 5 y. We would also argue,
however, that Africa has been labelled inappropriately as a
vast expanse of holoendemic transmission, intractable to
control. Less than a third of all surveys retrieved from AFRO
(29%) reported parasite prevalence above 50%, and, as has
been described, these results followed closely the distribution
of A. gambiae s.s. [54]. The conditions of hypoendemic and
mesoendemic transmission were common in surveys con-
ducted outside of this belt (which are not subject to the
ravages of this most efﬁcient vector) and are likely to beneﬁt
from approaches to prevention and control speciﬁc to the
underlying ecologic and epidemiologic conditions [15,69,70].
The descriptions of transmission intensity are dynamic and
the PfPR2–10 estimates in Africa (Figure 2) do not correspond
to levels of endemicity described four decades ago [17]. In the
AFRO region, there has been a recent expansion of
insecticide-treated net coverage and provision of effective
Figure 6. Box and Whisker Plots of PfPR2–10 by Period and WHO Regions
Thick black lines are the medians, and the light-blue boxes represent
interquartile ranges; whiskers show extreme, non-outlier observations.
Empty circles represent mild and/or extreme outliers. Sample sizes
correspond to those shown in Table 2.
doi:10.1371/journal.pmed.0050038.g006
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medicines. These programmatic successes are showing tangi-
ble impacts on mortality [8,9,71] and morbidity [8,9,72], and it
would seem entirely plausible that similar effects will be
operating at the level of transmission. If Africa is undergoing
a malaria epidemiological transition, capturing this dynamic
through mapped information on infection prevalence, and
planning accordingly, should be high on the control agenda.
The current focus of the Roll Back Malaria movement is,
appropriately, in Africa, as this continent bears the brunt of
malaria morbidity and mortality [73,74] and the descriptions
presented here reinforce this view. P. falciparum transmission
is a global problem, however, requiring a global strategy with
regional targets and approaches tailored to what can be
achieved within deﬁned intervention periods [61]. This
strategic planning demands an epidemiologically consistent
map that is constantly updated. The assembly of risk data
presented here represents the ﬁrst attempt to combine
disparate sources of malariometric data that should serve as
a dynamic platform to deﬁne a global strategy and map its
progress over the coming decades. The maps and national
levels of population at unstable and stable risk are released in
the public domain, with the publication of this paper, to
further that global effort (MAP, http://www.map.ox.ac.uk).
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Editors’ Summary
Background. Malaria is a parasitic disease that occurs in tropical and
subtropical regions of the world. 500 million cases of malaria occur every
year, and one million people, mostly children living in sub-Saharan Africa,
die as a result. The parasite mainly responsible for these deaths—
Plasmodium falciparum—is transmitted to people through the bites of
infected mosquitoes. These insects inject a life stage of the parasite
called sporozoites, which invade and reproduce in human liver cells.
After a few days, the liver cells release merozoites (another life stage of
the parasite), which invade red blood cells. Here, they multiply before
bursting out and infecting more red blood cells, causing fever and
damaging vital organs. Infected red blood cells also release gametocytes,
which infect mosquitoes when they take a human blood meal. In the
mosquito, the gametocytes multiply and develop into sporozoites, thus
completing the parasite’s life cycle. Malaria can be treated with
antimalarial drugs and can be prevented by controlling the mosquitoes
that spread the parasite (for example, by using insecticides) and by
avoiding mosquito bites (for example, by sleeping under a insecticide-
treated bednet).
Why Was This Study Done? Because malaria poses such a large global
public-health burden, many national and international agencies give
countries where malaria is endemic (always present) financial resources
for malaria control and, where feasible, elimination. The efficient
allocation of these resources requires accurate information on the
geographical distribution of malaria risk, but it has been 40 years since a
map of malaria risk was assembled. In this study, which is part of the
Malaria Atlas Project, the researchers have generated a new global map
to show where the risk of P. falciparum transmission is moderate or high
(stable transmission areas where malaria is endemic) and areas where the
risk of transmission is low (unstable transmission areas where sporadic
outbreaks of malaria occur).
What Did the Researchers Do and Find? To construct their map of P.
falciparum risk, the researchers collected nationally reported data on
malaria cases each year and on the number of people infected in
sampled communities. They also collected information about climatic
conditions that affect the parasite’s life cycle and consequently the
likelihood of active transmission. For example, below a certain temper-
ature, infected mosquitoes reach the end of their natural life span before
the parasite has had time to turn into infectious sporozoites, which
means that malaria transmission does not occur. By combining these
different pieces of information with global population data, the
researchers calculated that 2.37 billion people (about 35% of the world’s
population) live in areas where there is some risk of P. falciparum
transmission, and that about 1 billion of these people live where there is
a low but still present risk of malaria transmission. Furthermore, nearly all
the regions where more than half of children carry P. falciparum parasites
(a P. falciparum prevalence of more than 50%) are in Africa, although
there are some African regions where few people are infected with P.
falciparum. Outside Africa, the P. falciparum prevalence is generally
below 5%.
What Do These Findings Mean? The accuracy of this new map of the
spatial distribution of P. falciparum malaria risk depends on the
assumptions made in its assembly and the accuracy of the data fed
into it. Nevertheless, by providing a contemporary indication of global
patterns of P. falciparum malaria risk, this new map should be a valuable
resource for agencies that are trying to control and eliminate malaria. (A
similar map for the more common but less deadly P. vivax malaria would
also be useful, but has not yet been constructed because less
information is available and its biology is more complex.) Importantly,
the map provides an estimate of the number of people who are living in
areas where malaria transmission is low, areas where it should, in
princple, be possible to use existing interventions to eliminate the
parasite. In addition, it identifies large regions of Africa where the
parasite might be more amenable to control and, ultimately, elimination
than previously thought. Finally, with regular updates, this map will
make it possible to monitor the progress of malaria control and
elimination efforts.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050038.
 The MedlinePlus encyclopedia contains a page on malaria (in English
and Spanish)
 Information is available from the World Health Organization on malaria
(in English, Spanish, French, Russian, Arabic, and Chinese)
 The US Centers for Disease Control and Prevention provide informa-
tion on malaria (in English and Spanish)
 Information is available from the Roll Back Malaria Partnership on its
approach to the global control of malaria
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